KEYWORDS
Treatment Considerations, Combination Therapy, Drug Development, Non-Biological Therapies, Chemotherapy, Diseases, Lymphoid Malignancies, Lymphoid Leukemias, Myeloid Malignancies, Acute Myeloid Malignancies, Measurable Residual Disease, ALL, Research, AML, Clinical Research, Clinical Trials, Study Population, Human, Pediatric